Eric L. Simpson - Publications, H-index & Citations

Eric L. Simpson

oregon health & science university

53H指数

268论文数

1.6W被引数

收录论文 127

发表时间

Health Domains and Outcome Measurement Instruments in Adult Vulvovaginal Lichen Planus Studies: A Scoping Review 成人外阴阴道扁平苔藓研究中的健康领域与结局测量工具：一项范围综述

British Journal of Dermatology

IF9.6

2026-09-10

PREAI

Jaclyn Roland-McGowan; Eric L Simpson; Catherine M Leclair; Erin L Foster

Facial Rash Events in Dupilumab Phase 3 Atopic Dermatitis Trials: A Pooled Analysis Dupilumab第3期特应性皮炎试验中的面部皮疹事件：一项合并分析

Dermatitis

IF3.2

2025-10-29

PREAI

Amy S. Paller; Marjolein de Bruin-Weller; Eric L. Simpson; Jiyoung Ahn; Raj Chovatiya; Mette Deleuran; Golara Honari; Guy Gherardi; Anna Coleman; Emma Lawless; Zhen Chen; Brad Shumel; Ana B. Rossi

Improving the quality of atopic dermatitis epidemiological research in the United States- A systematic review of disease definitions and related content in national surveys 改善美国特应性皮炎流行病学研究的质量——一项关于疾病定义和国家调查相关内容的系统综述

Journal of Investigative Dermatology

IF5.7

2025-08-13

PREAI

Sarah L. Becker; Gina N. Bash; Wendy Smith Begolka; Tenesha Wallace-Hood; Junko Takeshita; Aaron M. Drucker; Jonathan Silverberg; Lawrence F. Eichenfield; Katrina Abuabara; Bryan Dosono; Andrew Hamilton; Robyn Okereke; Eric Simpson

Clinically Meaningful Improvements in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab who did not Achieve Clear or Almost Clear Skin at Week 16 临床上有意义的改善：在未于第16周达到皮肤清除或近乎清除的中度至重度特应性皮炎青少年患者中使用Tralokinumab治疗的情况

Dermatology and Therapy

IF4.2

2025-07-28

OAAI

Amy S. Paller; Andrew Blauvelt; Weily Soong; H. Chih-ho Hong; Marie L. A. Schuttelaar; Shannon K. R. Schneider; Eric L. Simpson

Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study 鲁索利替尼乳膏在2至11岁特应性皮炎儿童中的疗效与安全性：来自TRuE-AD3（一项III期随机双盲研究）的结果

Journal of the American Academy of Dermatology

IF11.8

2025-05-14

PREAI

Lawrence F. Eichenfield; Linda F. Stein Gold; Eric L. Simpson; Andrea L. Zaenglein; April W. Armstrong; Megha M. Tollefson; Weily Soong; Lara Wine Lee; Alim R. Devani; Seth B. Forman; Dareen D. Siri; Howard Kallender; Brett Angel; Qian Li; Xuejun Chen; Amy S. Paller

How do atopic dermatitis trialists perceive the Harmonising Outcomes Measurement in Eczema (HOME) core outcome set? A survey study from the HOME initiative 特应性皮炎临床试验研究者如何看待湿疹结果测量协调（Harmonising Outcomes Measurement in Eczema, HOME）核心结局指标集？一项来自HOME倡议的调查研究

Clinical and Experimental Dermatology

IF2.8

2025-04-25

PREAI

Yuval Gilad; Eric L Simpson; Christian Apfelbacher; Phyllis I Spuls; Kim S Thomas; Jochen Schmitt; Louise A A Gerbens; Michael E Jacobson; Norito Katoh; Hywel C Williams; Yael A Leshem

Achieving Long-Term Control in Atopic Dermatitis: Emerging Concepts, Definitions, Flares, and Therapy 实现特应性皮炎的长期控制：新兴概念、定义、复发与治疗

The Journal of Allergy and Clinical Immunology: In Practice

IF0

2025-02-22

OAAI

Hywel C. Williams; Eric L. Simpson; Sinéad M. Langan; Amanda Roberts; Kim S. Thomas

Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial

DERMATITIS

IF3.2

2025-01-10

PREAI

Simpson, Eric L.; Eichenfield, Lawrence F.; Papp, Kim A.; Forman, Seth B.; Hebert, Adelaide A.; Gonzalez, Mercedes E.; Gooderham, Melinda J.; Hong, H. Chih-ho; Prajapati, Vimal H.; Guttman-Yassky, Emma; Silverberg, Jonathan I.; Seal, Melissa S.; Krupa, David; Almaraz, Erin; Hanna, Diane; Burnett, Patrick; Snyder, Scott; Chu, David H.; Higham, Robert C.; Berk, David R.

Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)奥瑞司米拉斯特，一种磷酸二酯酶4B/D抑制剂，在轻中度特应性皮炎中的疗效与安全性：一项多中心随机安慰剂对照的IIb期剂量探索研究（ADESOS）的疗效与安全性

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2025-01-07

PREAI

Silverberg, Jonathan, I; Eichenfield, Lawrence F.; Blauvelt, Andrew; Irvine, Alan D.; Guttman-Yassky, Emma; Langley, Richard G.; Warren, Richard B.; French, Lars E.; Felding, Jakob; Weiss, Anne; Pedersen, Claus B.; Jensen, Morten L.; Carlsson, Anna; Sommer, Morten O. A.; Kjoller, Kim; Simpson, Eric L.

Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials Tapinarof乳膏每天1% 一次: 在关键的3期崇拜试验中，对成人和2岁以下儿童的中度至重度特应性皮炎的治疗效果显着

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2024-09-01

OAAI

Silverberg, Jonathan I.; Eichenfield, Lawrence F.; Hebert, Adelaide A.; Simpson, Eric L.; Gold, Linda Stein; Bissonnette, Robert; Papp, Kim A.; Browning, John; Kwong, Pearl; Korman, Neil J.; Brown, Philip M.; Rubenstein, David S.; Piscitelli, Stephen C.; Somerville, Matthew C.; Tallman, Anna M.; Kircik, Leon

Long-term dupilumab treatment is not associated with an increased overall risk of infections in adults with moderate-to-severe atopic dermatitis

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-08-08

PREAI

Beck, Lisa A.; Simpson, Eric L.; Thaci, Diamant; de Bruin-Weller, Marjolein; Deleuran, Mette; Kataoka, Yoko; Friedman, Adam J.; Khokhar, Faisal A.; Coleman, Anna; Gherardi, Guy; Chen, Zhen; Avetisova, Elena; Zhang, Annie; Nguyen, Tien, V

Long-term safety and efficacy of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis: a 52-week, phase 3, open-label extension trial

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-08-08

PREAI

Simpson, Eric L.; Eichenfield, Lawrence F.; Papp, Kim A.; Forman, Seth; Hebert, Adelaide A.; Gonzalez, Mercedes E.; Gooderham, Melinda; Hong, H. Chih-ho; Prajapati, Vimal H.; Guttman, Emma; Silverberg, Jonathan; Seal, Melissa; Krupa, David; Burnett, Patrick; Synder, Scott; Chu, David H.; Higham, Robert C.; Berk, David R.

Real-world effectiveness of persistent tralokinumab use on clinician and patient-reported outcomes in patients with atopic dermatitis in the CorEvitas atopic dermatitis registry 在CorEvitas特应性皮炎注册表中，持续使用tralokinumab对特应性皮炎患者的临床和患者报告结果的真实效果

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-08-08

PREAI

Silverberg, Jonathan; Balu, Sanjeev; Choi, C. Jean; Li, Alvin; Pugach, Oksana; Schneider, Shannon; Simpson, Eric

Real-world baseline characteristics and persistence in adult patients initiating tralokinumab in the CorEvitas atopic dermatitis registry 在CorEvitas特应性皮炎登记处开始tralokinumab的成年患者的真实世界基线特征和持久性

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-08-08

OAAI

Simpson, Eric; Balu, Sanjeev; Choi, C. Jean; Li, Alvin; Pugach, Oksana; Schneider, Shannon; Silverberg, Jonathan

Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 trials of adults and children with atopic dermatitis

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-08-08

PREAI

Simpson, Eric; Boguniewicz, Mark; Eichenfield, Lawrence; Gonzales, Mercedes E.; Hebert, Adelaide A.; Prajapati, Vimal H.; Gooderham, Melinda; Krupa, David; Chu, David H.; Higham, Robert C.; Berk, David R.

Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with moderate and/or more extensive atopic dermatitis: subgroup analysis from the TRuE-AD3 study ruxolitinib乳膏在2至11岁中度和/或更广泛的特应性皮炎儿童中的疗效和安全性: 来自TRuE-AD3研究的亚组分析

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-08-08

PREAI

Eichenfield, Lawrence F.; Armstrong, April W.; Gold, Linda F. Stein; Zaenglein, Andrea L.; Lee, Lara Wine; Brar, Kanwaljit K.; Joyce, Joel C.; Holland, Kristen E.; Angel, Brett; Sturm, Daniel; Li, Qian; Simpson, Eric L.

Characteristics of adult patients with atopic dermatitis initiating biologics and JAK inhibitors in the CorEvitas AD Registry 在CorEvitas AD注册表中，特应性皮炎起始生物制剂和JAK抑制剂的成年患者的特征

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-08-08

PREAI

Simpson, Eric; Fenske, Christian; Li, Alvin; Dawson, Zach; Maldonado, Yolanda Munoz; Ho, Kaylee; Callahan, Kayla; Gold, Linda Stein; Desai, Seemal; Golant, Alexandra; DiRuggiero, Douglas; Silverberg, Jonathan, I

671-Rapid and early onset of itch relief with tapinarof cream 1% once daily in two pivotal phase 3 trials in adults and children down to two years of age with atopic dermatitis 671-在成人和两岁以下儿童特应性皮炎的两项关键的3期试验中，每天一次1% tapinarof乳膏可快速和早期缓解瘙痒

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2024-08-08

PREAI

Simpson, Eric; Silverberg, Jonathan, I; Bissonnette, Robert; Gold, Linda Stein; Armstrong, April W.; Hebert, Adelaide A.; Serrao, Rocco T.; Jakus, Jeannette R.; Brown, Philip M.; Rubenstein, David S.; Piscitelli, Stephen C.; Tallman, Anna M.; Eichenfield, Lawrence F.

TikTok Misinformation on the Role of Diet in Atopic Dermatitis Management

DERMATITIS

IF3.2

2024-08-07

PREAI

Diehl, Kyra; Barber, Cara; Simpson, Eric L.; Banh, Marian; Cantu, Monique; Price, Kenna; Dao, Tiffany; Alcantara, Cheldon Ann; Yu, Tai Jung; Godil, Suha; Pham, Quang D.; Hosseinian, Kiana; Wisco, Oliver J.

Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations

DERMATOLOGY AND THERAPY

IF4.2

2024-07-02

OAAI

Gooderham, Melinda J.; de Bruin-Weller, Marjolein; Weidinger, Stephan; Cork, Michael J.; Eichenfield, Lawrence F.; Simpson, Eric L.; Tsianakas, Athanasios; Kerkmann, Urs; Feeney, Claire; Romero, William

研究方向